ARTISS Frozen is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Fibrinogen Human; Human Thrombin.
Product ID | 0944-8503_183b59f6-1e19-4a35-86f2-b2e77fdb2709 |
NDC | 0944-8503 |
Product Type | Human Prescription Drug |
Proprietary Name | ARTISS Frozen |
Generic Name | Fibrinogen Human Thrombin Human |
Dosage Form | Solution |
Route of Administration | TOPICAL |
Marketing Start Date | 2011-01-11 |
Marketing End Date | 2019-06-30 |
Marketing Category | BLA / BLA |
Application Number | BLA125266 |
Labeler Name | Baxalta US Inc. |
Substance Name | FIBRINOGEN HUMAN; HUMAN THROMBIN |
Active Ingredient Strength | 90 mg/mL; [iU]/mL |
Pharm Classes | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [CS],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 2011-01-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-03-08 |
Marketing End Date | 2019-07-31 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-01-11 |
Marketing End Date | 2019-06-30 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | ML |
Marketing Start Date | 2009-03-19 |
Marketing End Date | 2019-06-30 |
Ingredient | Strength |
---|---|
FIBRINOGEN HUMAN | 90 mg/mL |
SPL SET ID: | 13f76667-ec2f-4fa7-a9e8-12502d8224db |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ARTISS 78514937 3502970 Live/Registered |
Baxter International Inc. 2004-11-10 |